Co-Diagnostics Files to Sell Up to $25M in Stock

Sep

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Menu

Co-Diagnostics Files to Sell Up to $25M in Stock

To read the full story....

Breaking News

In Brief This Week: PerkinElmer, T2 Biosystems, Quest Diagnostics, and More

Foundation Medicine to Seek FDA Approval for FoundationOne as CDx to Genentech's Rozlytrek

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

OncoCyte Q2 Net Loss Rises

Agilent Q3 Revenues Up 6 Percent

Salveo Dx Merges With ImmunArray, Nudge

Featured White Papers

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

What's Popular?

FDA Stepping Up Actions Against PGx Testing, Forcing Some Labs to Stop Reporting Drug Information

Complex Genetic Testing Errors Emerge Amid Increasing Panel Use, Consumer Access, Case Series Finds

Inflammatix Preps Immune-Response Sepsis Dx for FDA Clinical Trial, Lays Out Future Test Plans

Myriad Genetics Stock Plummets on Lower-Than-Expected Q4 Revenues, FDA Interactions on GeneSight

Adaptive Biotechnologies Plans New Product Launches, Expanded FDA Label for ClonoSeq

Sponsorships